Previous close | 0.5800 |
Open | 0.5770 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.5581 - 0.5770 |
52-week range | 0.4390 - 10.8000 |
Volume | |
Avg. volume | 65,753 |
Market cap | 4.131M |
Beta (5Y monthly) | 0.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ATLANTA, May 22, 2024--Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
ATLANTA, May 14, 2024--Alzamend Neuro Announces Initial Closing of Private Placement; Investor Purchase Up to $25 Million of Preferred Shares; Proceeds for Clinical Trials
ATLANTA, May 09, 2024--Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of Up to $25 Million